New patent for Allergan Sales drug VRAYLAR

Annual Drug Patent Expirations for VRAYLAR Vraylar is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Allergan Sales drug VRAYLAR appeared first on DrugPatentWa…


New patent for Dow Pharm drug BRYHALI

Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Dow Pharm drug BRYHALI appeared first on DrugPatentWatc…


New patent for Napo Pharms drug MYTESI

Annual Drug Patent Expirations for MYTESI Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Napo Pharms drug MYTESI appeared first on DrugPatentWatch – Mak…


Which pharmaceutical companies have the most SPCs in Lithuania?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutic…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


Which pharmaceutical companies have the most SPCs in Lithuania?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutic…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


New patent expiration for Astellas drug VESICARE

Annual Drug Patent Expirations for VESICARE Vesicare is a drug marketed by Astellas and is included in one NDA. It is available from five suppliers. There is one patent protecting…
The post New patent expiration for Astellas drug VESICARE appeared firs…


Do NOT follow this link or you will be banned from the site!